SHILPAMED.NSSHILPAMED.NSNSE
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+5.0%
5Y CAGR+7.1%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+5.0%/yr
vs +50.3%/yr prior
5Y CAGR
+7.1%/yr
Consistent
Acceleration
-45.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$8.76B+23.5%
2024$7.10B+428.1%
2023$1.34B-82.2%
2022$7.56B+20.1%
2021$6.29B+1.3%
2020$6.21B+303.7%
2019$1.54B+4.0%
2018$1.48B-8.3%
2017$1.61B-37.1%
2016$2.57B-